Burlington-based Labcorp has launched the first blood-based test cleared by the U.S. Food and Drug Administration (FDA) for aiding in the diagnosis of Alzheimer's disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback